FPHAX Mutual Fund

NAV$34.31
Showing 10 of 60 holdings(as of Feb 28, 2026)Top 10 Weight: 75.56%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1LLYEli Lilly & Co25.18%362,801$381.66M••••••••••••••••••••••
2GSKGlaxosmithkline Finance Plc10.07%2,581,360$152.64M••••••••••••••••••••••
3JNJJohnson & Johnson7.53%459,700$114.20M••••••••••••••••••••••
4UCB:BRUcb Sa5.01%254,500$75.87M••••••••••••••••••••••
5AZN:LNAstraZeneca PLC4.93%358,250$74.68M••••••••••••••••••••••
6ROG:SMRoche Holding Ag - Participation4.93%157,090$74.76M••••••••••••••••••••••
7GILDGilead Sciences Inc4.64%472,500$70.38M••••••••••••••••••••••
8MRKMerck & Company Inc4.59%561,536$69.53M••••••••••••••••••••••
9ELANElanco Animal Health, Inc Cvr4.42%2,536,200$66.96M••••••••••••••••••••••
10NMFFidelity Securities Lending Cash Central Fund4.26%64,528,910$64.54M••••••••••••••••••••••
Want to see all 60 holdings?View All HoldingsPRO

Top Holdings Themes

PharmaceuticalsBiotechnologyMedical DevicesUrbanizationInflation ProtectionSocial ImpactInfrastructureImmunologyOncologyLife Sciences ToolsSemiconductorsAging Population

FPHAX Mutual Fund Top Holdings

FPHAX holdings top 10 positions. The top 10 holdings account for 75.6% of the fund, led by Eli Lilly & Co at 25.2%, Glaxosmithkline Finance Plc at 10.1%, Johnson & Johnson at 7.5%.

FPHAX portfolio concentration is relatively high, with the top 10 representing 75.6% of total assets. The largest sector exposure is Health Care at 83.0%.

FPHAX sector allocation provides a detailed breakdown. FPHAX overlap tool shows how holdings compare to other funds in your portfolio.